Lynx Biosciences | Reimagining Translational Research with Patient-Centric Models
Lynx Biosciences (LynxBio) is reshaping translational and reverse translational research by combining patient-derived cell models, microphysiological systems (MPS), and integrated multi-omic analyses to generate clinically meaningful insights—earlier and without reliance on animal models.
Our platform supports high-content functional profiling of antibody and cell-based therapies in complex ex vivo co-cultures. These models preserve the native biology of the tumor and immune microenvironment, enabling more predictive, human-relevant data from the outset.
As the field shifts toward more scalable, patient-centric approaches to drug development, LynxBio offers a solution built to meet this moment.
We work across oncology and immunology indications to:
• Profile therapeutic activity in ex vivo models
• Integrate imaging, cytokine analysis, and transcriptomics from the same culture
• Identify predictive biomarkers and stratify responders
• Uncover resistance mechanisms and guide target refinement
Our approach enables the resolution of responder and non-responder profiles, mechanistic biomarkers, and functional signatures from limited clinical material—accelerating the development of novel biologics and cell-engaging therapies.
Whether you are advancing bispecific antibodies, cell engagers, or radiotherapeutics, LynxBio offers a plug-in, human-relevant platform to de-risk development, guide patient selection, and inform smarter, earlier decisions.
Unlock deeper insight from fewer cells. Partner with LynxBio.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 3210 Merryfield Row, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lynxbiosciences.com
- Keywords
- Personalized Medicine, Hematological Malignancies, Multiple Myeloma, Leukemia, Companion Diagnostics, Biomarker Discovery, Drug Discovery, Microphysiological Systems, Organoids, Ex vivo models, TME assays.
- HQ
- San Diego, California
Lynx Biosciences, Inc. Questions
Lynx Biosciences, Inc.'s website is lynxbiosciences.com
Lynx Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/lynx-biosciences
Lynx Biosciences, Inc. has
12 employees.
View email and phone details for 12
employees at Lynx Biosciences, Inc..
Lynx Biosciences, Inc.'s industry is
Biotechnology Research
Lynx Biosciences, Inc.'s top competitors are
Levatio Therapeutics,
Lynx Therapeutics,
Kumquat Biosciences Inc.,
Poseida Therapeutics, Inc.,
Alkyon Therapeutics,
Phase Two Ventures,
Defined Bioscience,
Nanocellect Biomedical, Inc.,
Onlume,
Lynx Therapeutics Inc.
Lynx Biosciences, Inc.'s categories are Biotechnology Research
Lynx Biosciences, Inc.'s founding year is 2015
